<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34638785</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>19</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>28</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Molecular Insights into SARS-CoV2-Induced Alterations of the Gut/Brain Axis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">10440</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms221910440</ELocationID><Abstract><AbstractText>For a yet unknown reason, a substantial share of patients suffering from COVID-19 develop long-lasting neuropsychiatric symptoms ranging from cognitive deficits to mood disorders and/or an extreme fatigue. We previously reported that in non-neural cells, angiotensin-1 converting enzyme 2 (<i>ACE2</i>), the gene coding for the SARS-CoV2 host receptor, harbors tight co-expression links with dopa-decarboxylase (<i>DDC</i>), an enzyme involved in the metabolism of dopamine. Here, we mined and integrated data from distinct human expression atlases and found that, among a wide range of tissues and cells, enterocytes of the small intestine express the highest expression levels of <i>ACE2</i>, <i>DDC</i> and several key genes supporting the metabolism of neurotransmitters. Based on these results, we performed co-expression analyses on a recently published set of RNA-seq data obtained from SARS-CoV2-infected human intestinal organoids. We observed that in SARS-CoV2-infected enterocytes, <i>ACE2</i> co-regulates not only with <i>DDC</i> but also with a specific group of genes involved in (i) the dopamine/trace amines metabolic pathway, (ii) the absorption of microbiota-derived L-DOPA and (iii) the absorption of neutral amino acids serving as precursors to neurotransmitters. We conclude that in patients with long COVID, a chronic infection and inflammation of small intestine enterocytes might be indirectly responsible for prolonged brain alterations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nataf</LastName><ForeName>Serge</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>INSERM, Stem Cell and Brain Research Institute U1208, Univ Lyon, Universit&#xe9; Claude Bernard Lyon 1, 69500 Bron, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bank of Tissues and Cells, Lyon University Hospital (Hospices Civils de Lyon), 69003 Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pays</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-0720-2273</Identifier><AffiliationInfo><Affiliation>INSERM, Stem Cell and Brain Research Institute U1208, Univ Lyon, Universit&#xe9; Claude Bernard Lyon 1, 69500 Bron, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bank of Tissues and Cells, Lyon University Hospital (Hospices Civils de Lyon), 69003 Lyon, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="C000705307">ACE2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.1.1.28</RegistryNumber><NameOfSubstance UI="D001142">Aromatic-L-Amino-Acid Decarboxylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 4.1.1.28</RegistryNumber><NameOfSubstance UI="C000595218">DDC protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000085962" MajorTopicYN="N">Angiotensin-Converting Enzyme 2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001142" MajorTopicYN="N">Aromatic-L-Amino-Acid Decarboxylases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020895" MajorTopicYN="N">Enterocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="Y">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007421" MajorTopicYN="N">Intestine, Small</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">L-DOPA</Keyword><Keyword MajorTopicYN="N">SARS-CoV2</Keyword><Keyword MajorTopicYN="N">brain</Keyword><Keyword MajorTopicYN="N">enterocytes</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">monoamine oxidase</Keyword><Keyword MajorTopicYN="N">trace amines</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>13</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34638785</ArticleId><ArticleId IdType="pmc">PMC8508788</ArticleId><ArticleId IdType="doi">10.3390/ijms221910440</ArticleId><ArticleId IdType="pii">ijms221910440</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Taquet M., Luciano S., Geddes J.R., Harrison P.J. Bidirectional associations between COVID-19 and psychiatric disorder: Retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2021;8:130&#x2013;140. doi: 10.1016/S2215-0366(20)30462-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30462-4</ArticleId><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J., Kremer S., Merdji H., Clere-Jehl R., Schenck M., Kummerlen C., Collange O., Boulay C., Fafi-Kremer S., Ohana M., et al. Neurologic Features in Severe SARS-CoV-2 Infection. N. Engl. J. Med. 2020;382:2268&#x2013;2270. doi: 10.1056/NEJMc2008597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2008597</ArticleId><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Pun B.T., Badenes R., Heras La Calle G., Orun O.M., Chen W., Raman R., Simpson B.G.K., Wilson-Linville S., Hinojal Olmedillo B., Vallejo de la Cueva A., et al. Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): A multicentre cohort study. Lancet Respir. Med. 2021;9:239&#x2013;250. doi: 10.1016/S2213-2600(20)30552-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30552-X</ArticleId><ArticleId IdType="pmc">PMC7832119</ArticleId><ArticleId IdType="pubmed">33428871</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham E.L., Clark J.R., Orban Z.S., Lim P.H., Szymanski A.L., Taylor C., DiBiase R.M., Jia D.T., Balabanov R., Ho S.U., et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized COVID-19 &#x201c;long haulers&#x201d;. Ann. Clin. Transl. Neurol. 2021;8:1073&#x2013;1085. doi: 10.1002/acn3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S., Veldhuis A., Malhotra T. Neuropsychiatric and Cognitive Sequelae of COVID-19. Front. Psychol. 2021;12:577529. doi: 10.3389/fpsyg.2021.577529.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2021.577529</ArticleId><ArticleId IdType="pmc">PMC7960660</ArticleId><ArticleId IdType="pubmed">33737894</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: A retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427. doi: 10.1016/S2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall M. COVID and the brain: Researchers zero in on how damage occurs. Nature. 2021;595:484&#x2013;485. doi: 10.1038/d41586-021-01693-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-01693-6</ArticleId><ArticleId IdType="pubmed">34234323</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Zhang M., Garcia G., Tian E., Cui Q., Chen X., Sun G., Wang J., Arumugaswami V., Shi Y. ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response. Cell Stem Cell. 2021;28:331&#x2013;342.e5. doi: 10.1016/j.stem.2020.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2020.12.018</ArticleId><ArticleId IdType="pmc">PMC7832490</ArticleId><ArticleId IdType="pubmed">33450186</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y.C., Bai W.Z., Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J. Med. Virol. 2020;92:552&#x2013;555. doi: 10.1002/jmv.25728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25728</ArticleId><ArticleId IdType="pmc">PMC7228394</ArticleId><ArticleId IdType="pubmed">32104915</ArticleId></ArticleIdList></Reference><Reference><Citation>De Melo G.D., Lazarini F., Levallois S., Hautefort C., Michel V., Larrous F., Verillaud B., Aparicio C., Wagner S., Gheusi G., et al. COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci. Transl. Med. 2021;13:eabf8396. doi: 10.1126/scitranslmed.abf8396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abf8396</ArticleId><ArticleId IdType="pmc">PMC8158965</ArticleId><ArticleId IdType="pubmed">33941622</ArticleId></ArticleIdList></Reference><Reference><Citation>Troyer E.A., Kohn J.N., Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain. Behav. Immun. 2020;87:34&#x2013;39. doi: 10.1016/j.bbi.2020.04.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.04.027</ArticleId><ArticleId IdType="pmc">PMC7152874</ArticleId><ArticleId IdType="pubmed">32298803</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Q., Zheng Y., Shi J., Wang J., Li G., Li C., Fromson J.A., Xu Y., Liu X., Xu H., et al. Immediate psychological distress in quarantined patients with COVID-19 and its association with peripheral inflammation: A mixed-method study. Brain. Behav. Immun. 2020;88:17&#x2013;27. doi: 10.1016/j.bbi.2020.05.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.05.038</ArticleId><ArticleId IdType="pmc">PMC7235603</ArticleId><ArticleId IdType="pubmed">32416290</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakur K.T., Miller E.H., Glendinning M.D., Al-Dalahmah O., Banu M.A., Boehme A.K., Boubour A.L., Bruce S.S., Chong A.M., Claassen J., et al. COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital. Brain. 2021:awab148. doi: 10.1093/brain/awab148. in press.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab148</ArticleId><ArticleId IdType="pmc">PMC8083258</ArticleId><ArticleId IdType="pubmed">33856027</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Y., Wu J., Chen T., Li J., Zhang G., Wu D., Zhou Y., Zheng N., Cai A., Ning Q., et al. Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations. J. Clin. Investig. 2021;131 doi: 10.1172/JCI147329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI147329</ArticleId><ArticleId IdType="pmc">PMC8262559</ArticleId><ArticleId IdType="pubmed">33630760</ArticleId></ArticleIdList></Reference><Reference><Citation>Sashindranath M., Nandurkar H.H. Endothelial dysfunction in the brain: Setting the stage for stroke and other cerebrovascular complications of COVID-19. Stroke. 2021;52:1895&#x2013;1904. doi: 10.1161/STROKEAHA.120.032711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.120.032711</ArticleId><ArticleId IdType="pmc">PMC8078121</ArticleId><ArticleId IdType="pubmed">33794655</ArticleId></ArticleIdList></Reference><Reference><Citation>Che Mohd Nassir C.M.N., Hashim S., Wong K.K., Abdul Halim S., Idris N.S., Jayabalan N., Guo D., Mustapha M. COVID-19 Infection and Circulating Microparticles&#x2014;Reviewing Evidence as Microthrombogenic Risk Factor for Cerebral Small Vessel Disease. Mol. Neurobiol. 2021;58:4188&#x2013;4215. doi: 10.1007/s12035-021-02457-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02457-z</ArticleId><ArticleId IdType="pmc">PMC8235918</ArticleId><ArticleId IdType="pubmed">34176095</ArticleId></ArticleIdList></Reference><Reference><Citation>Nataf S. An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID-19. J. Med. Virol. 2020;92:1743&#x2013;1744. doi: 10.1002/jmv.25826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25826</ArticleId><ArticleId IdType="pmc">PMC7228370</ArticleId><ArticleId IdType="pubmed">32246784</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu M.Y., Juorio A.V. Aromatic l-amino acid decarboxylase: Biological characterization and functional role. Gen. Pharmacol. 1995;26:681&#x2013;696. doi: 10.1016/0306-3623(94)00223-A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0306-3623(94)00223-A</ArticleId><ArticleId IdType="pubmed">7635243</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang R., Castro M.F.G., McCune B.T., Zeng Q., Rothlauf P.W., Sonnek N.M., Liu Z., Brulois K.F., Wang X., Greenberg H.B., et al. TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. Sci. Immunol. 2020;5:eabc3582. doi: 10.1126/sciimmunol.abc3582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abc3582</ArticleId><ArticleId IdType="pmc">PMC7285829</ArticleId><ArticleId IdType="pubmed">32404436</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Li H.B., Lyu J.R., Lei X.M., Li W., Wu G., Lyu J., Dai Z.M. Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection. Int. J. Infect. Dis. 2020;96:19&#x2013;24. doi: 10.1016/j.ijid.2020.04.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.04.027</ArticleId><ArticleId IdType="pmc">PMC7165079</ArticleId><ArticleId IdType="pubmed">32311451</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I., Timens W., Bulthuis M.L.C., Lely A.T., Navis G.J., van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 2004;203:631&#x2013;637. doi: 10.1002/path.1570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Camargo S.M.R., Singer D., Makrides V., Huggel K., Pos K.M., Wagner C.A., Kuba K., Danilczyk U., Skovby F., Kleta R., et al. Tissue-specific amino acid transporter partners ACE2 and collectrin differentially interact with hartnup mutations. Gastroenterology. 2009;136:872&#x2013;882. doi: 10.1053/j.gastro.2008.10.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2008.10.055</ArticleId><ArticleId IdType="pmc">PMC7094282</ArticleId><ArticleId IdType="pubmed">19185582</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin A.M., Young R.L., Leong L., Rogers G.B., Spencer N.J., Jessup C.F., Keating D.J. The diverse metabolic roles of peripheral serotonin. Endocrinology. 2017;158:1049&#x2013;1063. doi: 10.1210/en.2016-1839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2016-1839</ArticleId><ArticleId IdType="pubmed">28323941</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng J., Li Y., Li J., Shen L., Zhu L., Liang Y., Lin X., Jiao N., Cheng S., Huang Y., et al. Gastrointestinal sequelae 90 days after discharge for COVID-19. Lancet Gastroenterol. Hepatol. 2021;6:344&#x2013;346. doi: 10.1016/S2468-1253(21)00076-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(21)00076-5</ArticleId><ArticleId IdType="pmc">PMC7943402</ArticleId><ArticleId IdType="pubmed">33711290</ArticleId></ArticleIdList></Reference><Reference><Citation>Livanos A.E., Jha D., Cossarini F., Gonzalez-Reiche A.S., Tokuyama M., Aydillo T., Parigi T.L., Ladinsky M.S., Ramos I., Dunleavy K., et al. Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients with Gastrointestinal Symptoms. Gastroenterology. 2021;160:2435&#x2013;2450.e34. doi: 10.1053/j.gastro.2021.02.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2021.02.056</ArticleId><ArticleId IdType="pmc">PMC7931673</ArticleId><ArticleId IdType="pubmed">33676971</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C., Wang Z., Lorenzi J.C.C., Muecksch F., Finkin S., Tokuyama M., Cho A., Jankovic M., Schaefer-Babajew D., Oliveira T.Y., et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591:639&#x2013;644. doi: 10.1038/s41586-021-03207-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto T., Perlot T., Rehman A., Trichereau J., Ishiguro H., Paolino M., Sigl V., Hanada T., Hanada R., Lipinski S., et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature. 2012;487:477&#x2013;481. doi: 10.1038/nature11228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11228</ArticleId><ArticleId IdType="pmc">PMC7095315</ArticleId><ArticleId IdType="pubmed">22837003</ArticleId></ArticleIdList></Reference><Reference><Citation>Valles-Colomer M., Falony G., Darzi Y., Tigchelaar E.F., Wang J., Tito R.Y., Schiweck C., Kurilshikov A., Joossens M., Wijmenga C., et al. The neuroactive potential of the human gut microbiota in quality of life and depression. Nat. Microbiol. 2019;4:623&#x2013;632. doi: 10.1038/s41564-018-0337-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0337-x</ArticleId><ArticleId IdType="pubmed">30718848</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowak J.K., Lindstr&#xf8;m J.C., Kalla R., Ricanek P., Halfvarson J., Satsangi J. Age, Inflammation, and Disease Location Are Critical Determinants of Intestinal Expression of SARS-CoV-2 Receptor ACE2 and TMPRSS2 in Inflammatory Bowel Disease. Gastroenterology. 2020;159:1151&#x2013;1154.e2. doi: 10.1053/j.gastro.2020.05.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.030</ArticleId><ArticleId IdType="pmc">PMC7217073</ArticleId><ArticleId IdType="pubmed">32413354</ArticleId></ArticleIdList></Reference><Reference><Citation>Potdar A.A., Dube S., Naito T., Li K., Botwin G., Haritunians T., Li D., Casero D., Yang S., Bilsborough J., et al. Altered Intestinal ACE2 Levels Are Associated with Inflammation, Severe Disease, and Response to Anti-Cytokine Therapy in Inflammatory Bowel Disease. Gastroenterology. 2021;160:809&#x2013;822.e7. doi: 10.1053/j.gastro.2020.10.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.10.041</ArticleId><ArticleId IdType="pmc">PMC9671555</ArticleId><ArticleId IdType="pubmed">33160965</ArticleId></ArticleIdList></Reference><Reference><Citation>Verstockt B., Verstockt S., Abdu Rahiman S., Ke B.-J., Arnauts K., Cleynen I., Sabino J., Ferrante M., Matteoli G., Vermeire S. Intestinal Receptor of SARS-CoV-2 in Inflamed IBD Tissue Seems Downregulated by HNF4A in Ileum and Upregulated by Interferon Regulating Factors in Colon. J. Crohns. Colitis. 2021;15:485&#x2013;498. doi: 10.1093/ecco-jcc/jjaa185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ecco-jcc/jjaa185</ArticleId><ArticleId IdType="pmc">PMC7543339</ArticleId><ArticleId IdType="pubmed">32915959</ArticleId></ArticleIdList></Reference><Reference><Citation>Barberio B., Zamani M., Black C.J., Savarino E.V., Ford A.C. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: A systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 2021;6:359&#x2013;370. doi: 10.1016/S2468-1253(21)00014-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(21)00014-5</ArticleId><ArticleId IdType="pubmed">33721557</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernstein C.N., Hitchon C.A., Walld R., Bolton J.M., Sareen J., Walker J.R., Graff L.A., Patten S.B., Singer A., Lix L.M., et al. Increased Burden of Psychiatric Disorders in Inflammatory Bowel Disease. Inflamm. Bowel Dis. 2019;25:360&#x2013;368. doi: 10.1093/ibd/izy235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ibd/izy235</ArticleId><ArticleId IdType="pmc">PMC6391845</ArticleId><ArticleId IdType="pubmed">29986021</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers M.M., Beumer J., Van Der Vaart J., Knoops K., Puschhof J., Breugem T.I., Ravelli R.B.G., Van Schayck J.P., Mykytyn A.Z., Duimel H.Q., et al. SARS-CoV-2 productively infects human gut enterocytes. Science. 2020;369:50&#x2013;54. doi: 10.1126/science.abc1669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc1669</ArticleId><ArticleId IdType="pmc">PMC7199907</ArticleId><ArticleId IdType="pubmed">32358202</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Song W., Wang J., Wang T., Xiong X., Qi Z., Fu W., Yang X., Chen Y.-G. Single-cell transcriptome analysis reveals differential nutrient absorption functions in human intestine. J. Exp. Med. 2020;217 doi: 10.1084/jem.20191130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20191130</ArticleId><ArticleId IdType="pmc">PMC7041720</ArticleId><ArticleId IdType="pubmed">31753849</ArticleId></ArticleIdList></Reference><Reference><Citation>He X.C., Li L. Atlas of the human intestine. J. Exp. Med. 2020;217:e20191130. doi: 10.1084/jem.20191997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20191997</ArticleId><ArticleId IdType="pmc">PMC7041719</ArticleId><ArticleId IdType="pubmed">31922531</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang R., Grishagin I., Wang Y., Zhao T., Greene J., Obenauer J.C., Ngan D., Nguyen D.T., Guha R., Jadhav A., et al. The NCATS BioPlanet&#x2014;An integrated platform for exploring the universe of cellular signaling pathways for toxicology, systems biology, and chemical genomics. Front. Pharmacol. 2019;10:445. doi: 10.3389/fphar.2019.00445.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.00445</ArticleId><ArticleId IdType="pmc">PMC6524730</ArticleId><ArticleId IdType="pubmed">31133849</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein D.S., Swoboda K.J., Miles J.M., Coppack S.W., Aneman A., Holmes C., Lamensdorf I., Eisenhofer G. Sources and physiological significance of plasma dopamine sulfate. J. Clin. Endocrinol. Metab. 1999;84:2523&#x2013;2531. doi: 10.1210/jcem.84.7.5864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jcem.84.7.5864</ArticleId><ArticleId IdType="pubmed">10404831</ArticleId></ArticleIdList></Reference><Reference><Citation>Apaydin H., Ertan S., &#xd6;zekmek&#xe7;i S. Broad bean (Vicia faba)&#x2014;A natural source of L-dopa&#x2014;Prolongs &#x201c;on&#x201d; periods in patients with Parkinson&#x2019;s disease who have &#x201c;on-off&#x201d; fluctuations. Mov. Disord. 2000;15:164&#x2013;166. doi: 10.1002/1531-8257(200001)15:1&lt;164::AID-MDS1028&gt;3.0.CO;2-E.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1531-8257(200001)15:1&lt;164::AID-MDS1028&gt;3.0.CO;2-E</ArticleId><ArticleId IdType="pubmed">10634260</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira A., Maraschin M. Banana (Musa spp.) from peel to pulp: Ethnopharmacology, source of bioactive compounds and its relevance for human health. J. Ethnopharmacol. 2015;160:149&#x2013;163. doi: 10.1016/j.jep.2014.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2014.11.008</ArticleId><ArticleId IdType="pubmed">25449450</ArticleId></ArticleIdList></Reference><Reference><Citation>Cilia R., Laguna J., Cassani E., Cereda E., Pozzi N.G., Isaias I.U., Contin M., Barichella M., Pezzoli G. Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study. Neurology. 2017;89:432&#x2013;438. doi: 10.1212/WNL.0000000000004175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004175</ArticleId><ArticleId IdType="pmc">PMC5539737</ArticleId><ArticleId IdType="pubmed">28679598</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramya K.B., Thaakur S. Herbs containing L&#x2014;Dopa: An update. Anc. Sci. Life. 2007;27:50&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3330839</ArticleId><ArticleId IdType="pubmed">22557260</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiroi T., Imaoka S., Funae Y. Dopamine formation from tyramine by CYP2D6. Biochem. Biophys. Res. Commun. 1998;249:838&#x2013;843. doi: 10.1006/bbrc.1998.9232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.1998.9232</ArticleId><ArticleId IdType="pubmed">9731223</ArticleId></ArticleIdList></Reference><Reference><Citation>Pletscher A., Kunz E., Staebler H., Gey K.F. The uptake of tryptamine by brain in vivo and its alteration by drugs. Biochem. Pharmacol. 1963;12:1065&#x2013;1070. doi: 10.1016/0006-2952(63)90080-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-2952(63)90080-7</ArticleId><ArticleId IdType="pubmed">14074105</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitale A.A., Pomilio A.B., Ca&#xf1;ellas C.O., Vitale M.G., Putz E.M., Ciprian-Ollivier J. In vivo long-term kinetics of radiolabeled N,N-dimethyltryptamine and tryptamine. J. Nucl. Med. 2011;52:970&#x2013;977. doi: 10.2967/jnumed.110.083246.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.110.083246</ArticleId><ArticleId IdType="pubmed">21622895</ArticleId></ArticleIdList></Reference><Reference><Citation>Oldendorf W.H. Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. Am. J. Physiol. 1971;221:1629&#x2013;1639. doi: 10.1152/ajplegacy.1971.221.6.1629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplegacy.1971.221.6.1629</ArticleId><ArticleId IdType="pubmed">5124307</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H., Nwe P.K., Yang Y., Rosen C.E., Bielecka A.A., Kuchroo M., Cline G.W., Kruse A.C., Ring A.M., Crawford J.M., et al. A Forward Chemical Genetic Screen Reveals Gut Microbiota Metabolites That Modulate Host Physiology. Cell. 2019;177:1217&#x2013;1231.e18. doi: 10.1016/j.cell.2019.03.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.03.036</ArticleId><ArticleId IdType="pmc">PMC6536006</ArticleId><ArticleId IdType="pubmed">31006530</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz M.D., Canales J.J., Zucchi R., Espinoza S., Sukhanov I., Gainetdinov R.R. Trace amine-associated receptor 1: A multimodal therapeutic target for neuropsychiatric diseases. Expert Opin. Ther. Targets. 2018;22:513&#x2013;526. doi: 10.1080/14728222.2018.1480723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14728222.2018.1480723</ArticleId><ArticleId IdType="pubmed">29798691</ArticleId></ArticleIdList></Reference><Reference><Citation>Burchett S.A., Hicks T.P. The mysterious trace amines: Protean neuromodulators of synaptic transmission in mammalian brain. Prog. Neurobiol. 2006;79:223&#x2013;246. doi: 10.1016/j.pneurobio.2006.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2006.07.003</ArticleId><ArticleId IdType="pubmed">16962229</ArticleId></ArticleIdList></Reference><Reference><Citation>Gainetdinov R.R., Hoener M.C., Berry M.D. Trace amines and their receptors. Pharmacol. Rev. 2018;70:549&#x2013;620. doi: 10.1124/pr.117.015305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/pr.117.015305</ArticleId><ArticleId IdType="pubmed">29941461</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsden C.A., Curzon G. The contribution of tryptamine to the behavioural effects of l-tryptophan in tranylcypromine-treated rats. Psychopharmacology. 1978;57:71&#x2013;76. doi: 10.1007/BF00426960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00426960</ArticleId><ArticleId IdType="pubmed">149328</ArticleId></ArticleIdList></Reference><Reference><Citation>Bieck P.R., Antonin K.H. Monoamine oxidase inhibition by tranylcypromine: Assessment in human volunteers. Eur. J. Clin. Pharmacol. 1982;22:301&#x2013;308. doi: 10.1007/BF00548397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00548397</ArticleId><ArticleId IdType="pubmed">7106165</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimsby J., Toth M., Chen K., Kumazawa T., Klaidman L., Adams J.D., Karoum F., Gal J., Shih J.C. Increased stress response and p-phenylethylamine in maob-def icient mice. Nat. Genet. 1997;17:210. doi: 10.1038/ng1097-206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1097-206</ArticleId><ArticleId IdType="pubmed">9326944</ArticleId></ArticleIdList></Reference><Reference><Citation>Birkmayer W., Riederer P., Linauer W., Knoll J. L-deprenyl plus l-phenylalanine in the treatment of depression. J. Neural Transm. 1984;59:81&#x2013;87. doi: 10.1007/BF01249880.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01249880</ArticleId><ArticleId IdType="pubmed">6425455</ArticleId></ArticleIdList></Reference><Reference><Citation>Youdim M.B.H., Weinstock M. Therapeutic Applications of Selective and Non-Selective Inhibitors of Monoamine Oxidase A and B that do not Cause Significant Tyramine Potentiation. Neurotoxicology. 2004;25:243&#x2013;250. doi: 10.1016/S0161-813X(03)00103-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0161-813X(03)00103-7</ArticleId><ArticleId IdType="pubmed">14697899</ArticleId></ArticleIdList></Reference><Reference><Citation>Finberg J.P.M., Gillman K. Selective inhibitors of monoamine oxidase type B and the &#x201c;cheese effect&#x201d;. Int. Rev. Neurobiol. 2011;100:169&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pubmed">21971008</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi &#xc1;.D., de Ara&#xfa;jo J.L.F., de Almeida T.B., Ribeiro-Alves M., de Almeida Velozo C., de Almeida J.M., de Carvalho Leit&#xe3;o I., Ferreira S.N., da Silva Oliveira J., Alves H.J., et al. Association between ACE2 and TMPRSS2 nasopharyngeal expression and COVID-19 respiratory distress. Sci. Rep. 2021;11:9658. doi: 10.1038/s41598-021-88944-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-88944-8</ArticleId><ArticleId IdType="pmc">PMC8102547</ArticleId><ArticleId IdType="pubmed">33958627</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J., Ye F., Wu A., Yang R., Pan M., Sheng J., Zhu W., Mao L., Wang M., Xia Z., et al. Comparative Transcriptome Analysis Reveals the Intensive Early Stage Responses of Host Cells to SARS-CoV-2 Infection. Front. Microbiol. 2020;11:593857. doi: 10.3389/fmicb.2020.593857.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.593857</ArticleId><ArticleId IdType="pmc">PMC7723856</ArticleId><ArticleId IdType="pubmed">33324374</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuba K., Imai Y., Rao S., Gao H., Guo F., Guan B., Huan Y., Yang P., Zhang Y., Deng W., et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat. Med. 2005;11:875&#x2013;879. doi: 10.1038/nm1267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1267</ArticleId><ArticleId IdType="pmc">PMC7095783</ArticleId><ArticleId IdType="pubmed">16007097</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer D., Camargo S.M.R., Ramadan T., Sch&#xe4;fer M., Mariotta L., Herzog B., Huggel K., Wolfer D., Werner S., Penninger J.M., et al. Defective intestinal amino acid absorption in Ace2 null mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2012;303:G686&#x2013;G695. doi: 10.1152/ajpgi.00140.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpgi.00140.2012</ArticleId><ArticleId IdType="pubmed">22790597</ArticleId></ArticleIdList></Reference><Reference><Citation>Alenina N., Bader M. ACE2 in Brain Physiology and Pathophysiology: Evidence from Transgenic Animal Models. Neurochem. Res. 2019;44:1323&#x2013;1329. doi: 10.1007/s11064-018-2679-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-018-2679-4</ArticleId><ArticleId IdType="pmc">PMC7089194</ArticleId><ArticleId IdType="pubmed">30443713</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahmoush A.J., Alpers D.H., Feigin R.D., Armbrustmacher V., Prensky A.L. Hartnup Disease: Clinical, Pathological, and Biochemical Observations. Arch. Neurol. 1976;33:797&#x2013;807. doi: 10.1001/archneur.1976.00500120001001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1976.00500120001001</ArticleId><ArticleId IdType="pubmed">999542</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x17d;igman T., Petkovi&#x107; Ramad&#x17e;a D., &#x160;imi&#x107; G., Bari&#x107; I. Inborn Errors of Metabolism Associated with Autism Spectrum Disorders: Approaches to Intervention. Front. Neurosci. 2021;15:673600. doi: 10.3389/fnins.2021.673600.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.673600</ArticleId><ArticleId IdType="pmc">PMC8193223</ArticleId><ArticleId IdType="pubmed">34121999</ArticleId></ArticleIdList></Reference><Reference><Citation>Conio B., Martino M., Magioncalda P., Escelsior A., Inglese M., Amore M., Northoff G. Opposite effects of dopamine and serotonin on resting-state networks: Review and implications for psychiatric disorders. Mol. Psychiatry. 2020;25:82&#x2013;93. doi: 10.1038/s41380-019-0406-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-019-0406-4</ArticleId><ArticleId IdType="pubmed">30953003</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutigliano G., Zucchi R. Molecular Variants in Human Trace Amine-Associated Receptors and Their Implications in Mental and Metabolic Disorders. Cell. Mol. Neurobiol. 2020;40:239&#x2013;255. doi: 10.1007/s10571-019-00743-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-019-00743-y</ArticleId><ArticleId IdType="pmc">PMC7028809</ArticleId><ArticleId IdType="pubmed">31643000</ArticleId></ArticleIdList></Reference><Reference><Citation>Arjmand S., Behzadi M., Stephens G.J., Ezzatabadipour S., Seifaddini R., Arjmand S., Shabani M. A Brain on a Roller Coaster: Can the Dopamine Reward System Act as a Protagonist to Subdue the Ups and Downs of Bipolar Disorder? Neuroscientist. 2018;24:423&#x2013;439. doi: 10.1177/1073858417714226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858417714226</ArticleId><ArticleId IdType="pubmed">28612649</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlet H.H., Pscheidt G.R., Spaide J.K., Himwich H.E. Variations of urinary creatinine and its correlation to tryptamine excretion in schizophrenic patients. Nature. 1964;203:1198&#x2013;1199. doi: 10.1038/2031198a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/2031198a0</ArticleId><ArticleId IdType="pubmed">14213691</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;reilly R.L., Davis B.A. Phenylethylamine and schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry. 1994;18:63&#x2013;75. doi: 10.1016/0278-5846(94)90024-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0278-5846(94)90024-8</ArticleId><ArticleId IdType="pubmed">7906896</ArticleId></ArticleIdList></Reference><Reference><Citation>McCutcheon R.A., Abi-Dargham A., Howes O.D. Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms. Trends Neurosci. 2019;42:205&#x2013;220. doi: 10.1016/j.tins.2018.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2018.12.004</ArticleId><ArticleId IdType="pmc">PMC6401206</ArticleId><ArticleId IdType="pubmed">30621912</ArticleId></ArticleIdList></Reference><Reference><Citation>Acharya S., Kim K.M. Roles of the functional interaction between brain cholinergic and dopaminergic systems in the pathogenesis and treatment of schizophrenia and Parkinson&#x2019;s disease. Int. J. Mol. Sci. 2021;22:4299. doi: 10.3390/ijms22094299.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22094299</ArticleId><ArticleId IdType="pmc">PMC8122651</ArticleId><ArticleId IdType="pubmed">33919025</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas T., Stefanoni D., Reisz J.A., Nemkov T., Bertolone L., Francis R.O., Hudson K.E., Zimring J.C., Hansen K.C., Hod E.A., et al. COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. JCI Insight. 2020;5:e140327. doi: 10.1172/jci.insight.140327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.140327</ArticleId><ArticleId IdType="pmc">PMC7453907</ArticleId><ArticleId IdType="pubmed">32559180</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J.W., Lam S.M., Fan X., Cao W.J., Wang S.Y., Tian H., Chua G.H., Zhang C., Meng F.P., Xu Z., et al. Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis. Cell Metab. 2020;32:188&#x2013;202.e5. doi: 10.1016/j.cmet.2020.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.06.016</ArticleId><ArticleId IdType="pmc">PMC7311890</ArticleId><ArticleId IdType="pubmed">32610096</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard K., Hume R., Kaptein E., Stanley E.L., Visser T.J., Coughtrie M.W.H. Sulfation of Thyroid Hormone and Dopamine during Human Development: Ontogeny of Phenol Sulfotransferases and Arylsulfatase in Liver, Lung, and Brain 1. J. Clin. Endocrinol. Metab. 2001;86:2734&#x2013;2742. doi: 10.1210/jc.86.6.2734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.86.6.2734</ArticleId><ArticleId IdType="pubmed">11397879</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Tong Q., Ma S.R., Zhao Z.X., Bin Pan L., Cong L., Han P., Peng R., Yu H., Lin Y., et al. Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson&#x2019;s disease by regulating gut microbiota. Signal. Transduct. Target. Ther. 2021;6:77. doi: 10.1038/s41392-020-00456-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00456-5</ArticleId><ArticleId IdType="pmc">PMC7902645</ArticleId><ArticleId IdType="pubmed">33623004</ArticleId></ArticleIdList></Reference><Reference><Citation>Camargo S.M.R., Vuille-Dit-Bille R.N., Mariotta L., Ramadan T., Huggel K., Singer D., G&#xf6;tze O., Verrey F. The molecular mechanism of intestinal levodopa absorption and its possible implications for the treatment of Parkinson&#x2019;s disease. J. Pharmacol. Exp. Ther. 2014;351:114&#x2013;123. doi: 10.1124/jpet.114.216317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.114.216317</ArticleId><ArticleId IdType="pubmed">25073474</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowsher R.R., Henry D.P. Decarboxylation of p-Tyrosine: A Potential Source of p-Tyramine in Mammalian Tissues. J. Neurochem. 1983;40:992&#x2013;1002. doi: 10.1111/j.1471-4159.1983.tb08083.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.1983.tb08083.x</ArticleId><ArticleId IdType="pubmed">6131938</ArticleId></ArticleIdList></Reference><Reference><Citation>Youdim M.B.H., Riederer P.F. A review of the mechanisms and role of monoamine oxidase inhibitors in Parkinson&#x2019;s. Neurology. 2004;63:S32&#x2013;S35. doi: 10.1212/WNL.63.7_suppl_2.S32.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.63.7_suppl_2.S32</ArticleId><ArticleId IdType="pubmed">15477584</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsugeno Y., Ito A. A key amino acid responsible for substrate selectivity of monoamine oxidase A and B. J. Biol. Chem. 1997;272:14033&#x2013;14036. doi: 10.1074/jbc.272.22.14033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.272.22.14033</ArticleId><ArticleId IdType="pubmed">9162023</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy D.L., Karoum F., Pickar D., Cohen R.M., Lipper S., Mellow A.M., Tariot P.N., Sunderland T. Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline) J. Neural Transm. Suppl. 1998;52:39&#x2013;48. doi: 10.1007/978-3-7091-6499-0_5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-7091-6499-0_5</ArticleId><ArticleId IdType="pubmed">9564606</ArticleId></ArticleIdList></Reference><Reference><Citation>Godefroy D., Rost&#xe8;ne W., Anouar Y., Goazigo A.R. Le Tyrosine-hydroxylase immunoreactivity in the mouse transparent brain and adrenal glands. J. Neural Transm. 2019;126:367&#x2013;375. doi: 10.1007/s00702-018-1925-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-018-1925-x</ArticleId><ArticleId IdType="pubmed">30206700</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhl&#xe9;n M., Fagerberg L., Hallstr&#xf6;m B.M., Lindskog C., Oksvold P., Mardinoglu A., Sivertsson &#xc5;., Kampf C., Sj&#xf6;stedt E., Asplund A., et al. Tissue-based map of the human proteome. Science. 2015;347:1260419. doi: 10.1126/science.1260419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1260419</ArticleId><ArticleId IdType="pubmed">25613900</ArticleId></ArticleIdList></Reference><Reference><Citation>Noguchi S., Arakawa T., Fukuda S., Furuno M., Hasegawa A., Hori F., Ishikawa-Kato S., Kaida K., Kaiho A., Kanamori-Katayama M., et al. FANTOM5 CAGE profiles of human and mouse samples. Sci. Data. 2017;4:170112. doi: 10.1038/sdata.2017.112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sdata.2017.112</ArticleId><ArticleId IdType="pmc">PMC5574368</ArticleId><ArticleId IdType="pubmed">28850106</ArticleId></ArticleIdList></Reference><Reference><Citation>Lonsdale J., Thomas J., Salvatore M., Phillips R., Lo E., Shad S., Hasz R., Walters G., Garcia F., Young N., et al. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 2013;45:580&#x2013;585. doi: 10.1038/ng.2653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2653</ArticleId><ArticleId IdType="pmc">PMC4010069</ArticleId><ArticleId IdType="pubmed">23715323</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., Amin N., Schwikowski B., Ideker T. Cytoscape: A software Environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498&#x2013;2504. doi: 10.1101/gr.1239303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.1239303</ArticleId><ArticleId IdType="pmc">PMC403769</ArticleId><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference><Reference><Citation>Franz M., Rodriguez H., Lopes C., Zuberi K., Montojo J., Bader G.D., Morris Q. GeneMANIA update 2018. Nucleic Acids Res. 2018;46:W60&#x2013;W64. doi: 10.1093/nar/gky311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky311</ArticleId><ArticleId IdType="pmc">PMC6030815</ArticleId><ArticleId IdType="pubmed">29912392</ArticleId></ArticleIdList></Reference><Reference><Citation>Nataf S., Barritault M., Pays L. A unique TGFB1-driven genomic program links astrocytosis, low-grade inflammation and partial demyelination in spinal cord periplaques from progressive multiple sclerosis patients. Int. J. Mol. Sci. 2017;18:97. doi: 10.3390/ijms18102097.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18102097</ArticleId><ArticleId IdType="pmc">PMC5666779</ArticleId><ArticleId IdType="pubmed">28981455</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeria M., Cejudo J.C., Sotoca J., Deus J., Krupinski J. Cognitive profile following COVID-19 infection: Clinical predictors leading to neuropsychological impairment. Brain Behav. Immun. Heal. 2020;9:100163. doi: 10.1016/j.bbih.2020.100163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2020.100163</ArticleId><ArticleId IdType="pmc">PMC7581383</ArticleId><ArticleId IdType="pubmed">33111132</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>